Very Late Recurrence of Hepatocellular Carcinoma After Liver Transplantation: Case Report and Literature Review

Transplantation Proceedings

Volumn 38, Issue 9, 2006, Pages 3140-3143

  Schreibman, I R ^a   Bejarano, P ^a   Martinez, E J ^a   Regev, A ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; AMLODIPINE; ARGININE DEIMINASE; DOXORUBICIN; FUROSEMIDE; INSULIN; PREDNISOLONE; THALIDOMIDE; TSUKUBAENOLIDE;

AGED; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; CLINICAL PROTOCOL; CYTOREDUCTIVE SURGERY; DIABETIC NEPHROPATHY; DISEASE COURSE; GLOMERULOSCLEROSIS; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; LAPAROTOMY; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LIVING DONOR; MALE; PATIENT ASSESSMENT; PATIENT MONITORING; PRIORITY JOURNAL; RECURRENT CANCER; TISSUE SECTION; UNSPECIFIED SIDE EFFECT;

AGED; BIOPSY; CARCINOMA, HEPATOCELLULAR; FATAL OUTCOME; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MAGNETIC RESONANCE IMAGING; MALE; RECURRENCE; TIME FACTORS;

EID: 33750965911     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.08.095     Document Type: Article

References (16)

1. Marsh J.W., Dvorchik I., Subotin M., et al. The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study. Hepatology 26 (1997) 444
2. El-Serag H.B., Davila J.A., Petersen N.J., et al. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 139 (2003) 817
3. El-Serag H.B. Hepatocellular carcinoma: recent trends in the United States. Gastreonterology 127 (2004) S27
4. Bosch F.X., Ribes J., Cleries R., et al. Epidemiology of hepatocellular carcinoma. Clin Liver Dis 9 (2005) 191
5. Roberts J.P. Tumor surveillance-what can and should be done?. Screening for recurrence of hepatocellular carcinoma after liver transplantation. Liver Transplantation 11 (2005) S45
6. Mazzaferro V., Regalia E., Doci R., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334 (1996) 693
7. Roayaie S., Schwartz J.D., Sung M.W., et al. Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis. Liver Transplantation 10 (2004) 534
8. Regalia E., Fassati L.R., Valente U., et al. Pattern and management of recurrent hepatocellular carcinoma after liver transplantation. J Hepat Bil Pancr Surg 5 (1998) 29
9. Merli M., Gentili F., Novelli G., et al. Predictive factors of outcome after liver transplantation in patients with cirrhosis and hepatocellular carcinoma. Transplant Proc 37 (2005) 2535
10. Schlitt H.J., Neipp M., Weimann A., et al. Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation. J Clin Oncol 17 (1999) 324
11. Yao F.Y., Kinhabwala M., LaBerge J.M., et al. The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma. Am J Transpl 5 (2005) 795
12. Shiffman M.L. Natural history and risk factors for progression of hepatitis C virus disease and development of hepatocellular cancer before liver transplantation. Liver Transpl 9 (2003) S14
13. Bajaj J.S., Molina E., Regev A., et al. Pretreatment laparoscopic appearance of the liver can predict response to combination therapy with interferon alpha 2B and ribavirin in chronic hepatitis C. Gastrointest Endosc 58 (2003) 380
14. Columbo M. In: Schiff E.R., Sorrell M.F., and Maddrey W.C. (Eds). Schiff's Diseases of the Liver. 9th ed. (2003), Lippincott, Williams and Wilkins, Philadelphia
15. Okazaki N., Yoshino M., Yoshida T., et al. Evaluation of the prognosis for small hepatocellular carcinoma based on tumor volume doubling time. A preliminary report. Cancer 63 (1989) 2207
16. Ebara M., Ohto M., Shinagawa T., et al. Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. A study in twenty-two patients. Gastroenterology 90 (1986) 289